Literature DB >> 28920583

Ebosin: a potential therapeutic agent for rheumatoid arthritis and autoinflammatory syndromes.

Yang Zhang1, Lifei Wang1, Yuan Li1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28920583      PMCID： PMC5827182          DOI： 10.1038/cmi.2017.90

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  16 in total

1.  Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.

Authors:  Marc Feldmann; Ravinder N Maini
Journal:  Nat Med       Date:  2003-10       Impact factor: 53.440

Review 2.  Molecular mechanisms regulating NLRP3 inflammasome activation.

Authors:  Eun-Kyeong Jo; Jin Kyung Kim; Dong-Min Shin; Chihiro Sasakawa
Journal:  Cell Mol Immunol       Date:  2015-11-09       Impact factor: 11.530

Review 3.  Novel treatment strategies in rheumatoid arthritis.

Authors:  Gerd R Burmester; Janet E Pope
Journal:  Lancet       Date:  2017-06-10       Impact factor: 79.321

4.  Effect of ebosin on modulating interleukin-1β-induced inflammatory responses in rat fibroblast-like synoviocytes.

Authors:  Yang Zhang; Lifei Wang; Liping Bai; Rong Jiang; Lianhong Guo; Jianbo Wu; Guifang Cheng; Ren Zhang; Yuan Li
Journal:  Cell Mol Immunol       Date:  2015-05-04       Impact factor: 11.530

Review 5.  Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies.

Authors:  Giulio Cavalli; Charles A Dinarello
Journal:  Rheumatology (Oxford)       Date:  2015-07-23       Impact factor: 7.580

6.  Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.

Authors:  Hal M Hoffman; Martin L Throne; N J Amar; Mohamed Sebai; Alan J Kivitz; Arthur Kavanaugh; Steven P Weinstein; Pavel Belomestnov; George D Yancopoulos; Neil Stahl; Scott J Mellis
Journal:  Arthritis Rheum       Date:  2008-08

Review 7.  Evidence that cytokines play a role in rheumatoid arthritis.

Authors:  Fionula M Brennan; Iain B McInnes
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

Review 8.  Etanercept (SB4): A Review in Autoimmune Inflammatory Diseases.

Authors:  Celeste B Burness; Sean T Duggan
Journal:  BioDrugs       Date:  2016-08       Impact factor: 5.807

9.  Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study.

Authors:  Naomi Schlesinger; Eduardo Mysler; Hsiao-Yi Lin; Marc De Meulemeester; Jozef Rovensky; Udayasankar Arulmani; Alison Balfour; Gerhard Krammer; Peter Sallstig; Alexander So
Journal:  Ann Rheum Dis       Date:  2011-05-03       Impact factor: 19.103

Review 10.  Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses.

Authors:  Katrin D Mayer-Barber; Bo Yan
Journal:  Cell Mol Immunol       Date:  2016-06-06       Impact factor: 11.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.